Cargando…

FDG-PET in the evaluation of response to nivolumab in recurrent non-small-cell lung cancer

BACKGROUND: Nivolumab, an immune checkpoint inhibitor, is recently clinically applied to non-small cell lung cancer (NSCLC) treatment, and this causes T cell activation and T cell infiltration to tumor tissue through the blockade of the interaction between programmed cell death 1 (PD-1) and programm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Higuchi, Mitsunori, Owada, Yuki, Inoue, Takuya, Watanabe, Yuzuru, Yamaura, Takumi, Fukuhara, Mitsuro, Hasegawa, Takeo, Suzuki, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011843/ https://www.ncbi.nlm.nih.gov/pubmed/27595749 http://dx.doi.org/10.1186/s12957-016-0998-y

Ejemplares similares

Nivolumab-related severe thrombocytopenia in a patient with relapsed lung adenocarcinoma: a case report and review of the literature
por: Hasegawa, Takeo, et al.
Publicado: (2019)

Clinical significance of expanded Foxp3(+) Helios(−) regulatory T cells in patients with non-small cell lung cancer
por: MUTO, SATOSHI, et al.
Publicado: (2015)

Prognostic Impact of Hypoxia-Inducible miRNA-210 in Patients with Lung Adenocarcinoma
por: Osugi, Jun, et al.
Publicado: (2015)

The efficacy of the Kampo medicine rikkunshito for chemotherapy-induced anorexia (RICH trial): study protocol for a randomized controlled trial
por: Inoue, Takuya, et al.
Publicado: (2017)

Tumor β-catenin expression is associated with immune evasion in non-small cell lung cancer with high tumor mutation burden
por: Muto, Satoshi, et al.
Publicado: (2021)

Wnt/β-Catenin Signaling and Resistance to Immune Checkpoint Inhibitors: From Non-Small-Cell Lung Cancer to Other Cancers
por: Muto, Satoshi, et al.
Publicado: (2023)

A patient with ALK‐positive lung adenocarcinoma who survived alectinib‐refractory postoperative recurrence for 4 years by switching to ceritinib
por: Matsumura, Yuki, et al.
Publicado: (2021)

Successful Management of Crizotinib-Induced Neutropenia in a Patient with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Case Report
por: Osugi, Jun, et al.
Publicado: (2016)

Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer
por: Suzuki, Hiroyuki, et al.
Publicado: (2013)

Family with sequence similarity 83, member B is a predictor of poor prognosis and a potential therapeutic target for lung adenocarcinoma expressing wild-type epidermal growth factor receptor
por: Yamaura, Takumi, et al.
Publicado: (2018)

Diffuse Cystic Metastases in the Lung after Nivolumab Treatment in a Patient with Non-Small Cell Lung Cancer: A Case Report
por: Muto, Satoshi, et al.
Publicado: (2021)

Ground-glass nodule in a patient with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML4-ALK)-positive lung cancer: a case report
por: Owada, Yuki, et al.
Publicado: (2016)

Texture Analysis and Synthesis of Malignant and Benign Mediastinal Lymph Nodes in Patients with Lung Cancer on Computed Tomography
por: Pham, Tuan D., et al.
Publicado: (2017)

Brief report on similar mutational changes in neurofibromatosis type 2 gene in minute pulmonary meningothelial-like nodule and meningioma of the central nervous system
por: Higuchi, Mitsunori, et al.
Publicado: (2018)

Intrahepatic Cholangiolocellular and Cholangiocellular Carcinoma - Differences in the (18)F-FDG PET/CT Findings
por: Takahashi, Yoshiko, et al.
Publicado: (2017)

Prognostic value of morphological characteristics assessed by CT scan in patients with non‐small cell lung cancer treated with nivolumab
por: Minemura, Hiroyuki, et al.
Publicado: (2020)

A Case of Paraneoplastic Limbic Encephalitis in a Patient with Invasive Thymoma with Anti-Glutamate Receptor Antibody-Positive Cerebrospinal Fluid: A Case Report
por: Inoue, Takuya, et al.
Publicado: (2017)

Solitary Asymptomatic Thyroid Metastasis from Hepatocellular Carcinoma Detected by FDG-PET/CT
por: Toshima, Takeo, et al.
Publicado: (2010)

Staging recurrent ovarian cancer with (18)FDG PET/CT
por: DRAGOSAVAC, SANJA, et al.
Publicado: (2013)

Response to Immune Checkpoint Inhibitor Therapy in Patients with Unresectable Recurrent Malignant Pleural Mesothelioma Shown by FDG-PET and CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

Combination of FDG-PET and FMISO-PET as a treatment strategy for patients undergoing early-stage NSCLC stereotactic radiotherapy
por: Watanabe, Shiro, et al.
Publicado: (2019)

Predictive value of integrated (18)F-FDG PET/MRI in the early response to nivolumab in patients with previously treated non-small cell lung cancer
por: Umeda, Yukihiro, et al.
Publicado: (2020)

(18)FDG-PET/CT Specificity for the Detection of Lymphoma Recurrence in the Tonsils
por: West, Jonathan D., et al.
Publicado: (2021)

Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case report
por: Watanabe, Masayuki, et al.
Publicado: (2022)

FDG PET Imaging of the Pain Matrix in Neuropathic Pain Model Rats
por: Cui, Yilong, et al.
Publicado: (2022)

Efficacy of FDG-PET for defining gross tumor volume of head and neck cancer
por: Kajitani, Chikae, et al.
Publicado: (2013)

FDG-PET in lymphoma
por: Meignan, Michel
Publicado: (2014)

PET-FDG: Impetus
por: Nanni, Cristina
Publicado: (2020)

Role of FDG‐PET/MRI, FDG‐PET/CT, and Dynamic Susceptibility Contrast Perfusion MRI in Differentiating Radiation Necrosis from Tumor Recurrence in Glioblastomas
por: Hojjati, Mojgan, et al.
Publicado: (2017)

Intravascular large B-cell lymphoma with diffuse FDG uptake in the lung by (18)FDG-PET/CT without chest CT findings
por: Yamashita, Hiroyuki, et al.
Publicado: (2012)

False Positive FDG PET/CT of Recurrent Testicular Tumour Due to Orchitis
por: Mansberg, Robert, et al.
Publicado: (2014)

The Role of 18F-FDG PET/CT in the Evaluation of Gastric Cancer Recurrence
por: Cayvarlı, Hakan, et al.
Publicado: (2014)

Pulmonary Recurrence of Lymphomatoid Granulomatosis Diagnosed on F-18 FDG PET/CT
por: Sood, Apurva, et al.
Publicado: (2020)

Examining the evolving utility of (18)FDG-PET/CT in breast cancer recurrence
por: Djassemi, Navid, et al.
Publicado: (2020)

FDG PET/CT to Predict Recurrence of Early Breast Invasive Ductal Carcinoma
por: Jo, Joon-Hyung, et al.
Publicado: (2022)

Mediastinal Malignant Melanoma Markedly Shrinking in Response to Nivolumab
por: Sakaguchi, Hiroyuki, et al.
Publicado: (2021)

Grading Meningioma: A Comparative Study of Thallium-SPECT and FDG-PET
por: Okuchi, Sachi, et al.
Publicado: (2015)

FDG-PET and PET/CT - Part II
por: Takalkar, Amol M, et al.
Publicado: (2008)

A case of pancreatic schwannoma showing increased FDG uptake on PET/CT
por: Fukuhara, Sotaro, et al.
Publicado: (2017)

Evaluation of tocilizumab therapy in patients with rheumatoid arthritis based on FDG-PET/CT
por: Okamura, Koichi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ijs7r8jkej5p7u85odgd3m0sp1